Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppression.
Zahraeifard S, Xiao Z, So JY, Ahad A, Montoya S, Park WY, Sornapudi T, Andohkow T, Read A, Kedei N, Koparde V, Yang H, Lee M, Wong N, Cam M, Wang K, Ruppin E, Luo J, Hollander C, Yang L.
Nature Communications. 2024 July;15:5873. doi: 10.1038/s41467-024-50262-8
Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS- and BRAF-mutant cancer cells.
Zhang H, Read A, Cataisson C, Yang HH, Lee W-C, Turk BE, Yuspa SH, Luo J.
Science Signaling. 2024 May;17:eadd5073. doi: 10.1126/scisignal.add5073
Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.
Cornwell JA, Crncec A, Afifi MM, Tang K, Amin R, Cappell SD.
Nature. 2023 Jul;619(7969):363-370. doi: 10.1038/s41586-023-06274-3
Irreversible cell cycle exit associated with senescence is mediated by constitutive MYC degradation.
Afifi MM, Crncec A, Cornwell JA, Cataisson C, Paul D, Ghorab LM, Hernandez MO, Wong M, Kedei N, Cappell SD.
Cell Reports. 2023 Aug 31;42(9):113079. doi: 10.1016/j.celrep.2023.113079
A non-conserved histidine residue on KRAS drives paralog selectivity of the KRASG12D inhibitor MRTX1133.
Keats M, Han JJW, Lee Y-H, Lee C-S, Luo J.
Cancer Research. 2023 Sep 1;83(17):2816-2823. doi: 10.1158/0008-5472.CAN-23-0592
SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma.
Kim Y-I, Tseng Y-C, Ayaz G, Wang S, Yan H, du Bois W, Yang H, Zhen T, Lee MP, Liu P, Kaplan RN, Huang J.
Cell & Bioscience. 2023 Jul 25;13(1):136. doi: 10.1186/s13578-023-01088-2
Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway.
Park W-Y, Gray JM, Holewinski RJ, Andresson T, So JY, Carmona-Rivera C, Hollander MC, Yang HH, Lee M, Kaplan MJ, Cappell SD, Yang L.
Nature Cancer. 2023 Mar;4(3):419-435. doi: 10.1038/s43018-023-00524-z